Press Releases
  Date Title and Summary View
Oct 6, 2017
WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc., (NYSE:PKI) a global leader committed to innovating for a healthier world, today announced that on Thursday, November 2, 2017, after market close, the Company will release third quarter 2017 results. The Company will also host a conference call the same...
PDF
Sep 15, 2017
WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the upcoming retirement of Andy Wilson (age 59), senior vice president and chief financial officer (CFO). To provide appropriate time to identify a successor CFO...
PDF
Sep 14, 2017
In-Depth Genomics Leverages PerkinElmer's Comprehensive Sequencing Services toProvide Whole Genome Sequencing to Neurology Patients   National Society of Genetic Counselors Annual Conference, Columbus...
PDF
Sep 8, 2017
PDF
Sep 7, 2017
PDF
Aug 28, 2017
WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 15th annual Morgan Stanley Global Healthcare Conference on Monday, September 11, 2017 at 11:40 am ET at the Grand Hyatt New ...
PDF
Aug 23, 2017
WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Baird Global Healthcare Conference on Wednesday, September 6, 2017 at 10:50 am ET at the InterContinental New York Barclay. ...
PDF
Aug 3, 2017
GAAP and adjusted revenues of $547 million GAAP earnings per share from continuing operations of $0.57; Adjusted earnings per share of $0.67 GAAP operating margins expand by 150 basis points; Adjusted operating margins expand by 70 basis points ...
PDF
Aug 3, 2017
PerkinElmer Genetics Provides Complete Genomic Lab Testing Solution WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the launch of PerkinElmer Genetics' clinical genomics services. Through...
PDF
Jul 24, 2017
WALTHAM, Mass.--(BUSINESS WIRE)-- The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on July 24, 2017. This dividend is payable on November 10, 2017 to all shareholders of record at the close of business on October 20, 2017. ...
PDF
Page:
1
... NextLast